Double-Punch immunotherapy trial shows promise for lung cancer

NCT ID NCT03563716

Completed Disease control Sponsor: Genentech, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding a new drug called tiragolumab to an existing immunotherapy (atezolizumab) works better than the standard immunotherapy alone. It involved 135 people with advanced non-small cell lung cancer who had not yet received chemotherapy. The goal was to see if the drug combination could better control the cancer by helping the patient's own immune system fight it.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Arizona Oncology Associates, PC - HAL

Tempe, Arizona, 85284, United States
Asan Medical Center

Seoul, 05505, South Korea
Centre Georges François Leclerc

Dijon, 21079, France
Centro Medico Quironsalud Sagrado Corazon

Seville, 41013, Spain
Chang Gung Memorial Hospital - Linkou

Taoyuan District, 333, Taiwan
Chungbuk National University Hospital

Cheongju-si, 28644, South Korea
Clinica Universitaria Navarra (Madrid)

Madrid, 28036, Spain
Clinical Center of Serbia

Belgrade, 11000, Serbia
Clinical Hospital Center Bezanijska Kosa

Belgrade, 11070, Serbia
Complejo Hospitalario Universitario Insular?Materno Infantil

Las Palmas de Gran Canaria, LAS Palmas, 35016, Spain
Florida Cancer Specialists - NORTH - SCRI - PPDS

St. Petersburg, Florida, 33705, United States
Hopital Nord AP-HM

Marseille, 13015, France
Hospital General Universitario de Alicante

Alicante, 03010, Spain
Hospital Regional Universitario de Malaga ? Hospital General

Málaga, 29010, Spain
Hospital Univ Germans Trias i Pujol

Badalona, Barcelona, 8916, Spain
Hospital Universitario 12 de Octubre

Madrid, 28041, Spain
Hospital Universitario Puerta de Hierro - Majadahonda

Madrid, 28222, Spain
Hospital Universitario Vall d'Hebron - PPDS

Barcelona, 08035, Spain
Hospital Universitario Virgen del Rocio

Seville, 41013, Spain
ICO Paul Papin

Angers, 49055, France
Illinois Cancer Care

Peoria, Illinois, 61615, United States
Illinois Cancer Specialists

Arlington Heights, Illinois, 60005, United States
Institut Bergonié Centre Régional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest

Bordeaux, 33076, France
Institut De Cancerologie De L'Ouest

Saint-Herblain, 44115, France
Institute of Lung Diseases Vojvodina

Kamenitz, Južnobanatski Okrug, 21204, Serbia
Kangbuk Samsung Hospital

Seoul, 03181, South Korea
Karmanos Cancer Institute

Detroit, Michigan, 48201, United States
National Cheng Kung University Hospital

North Dist., 70403, Taiwan
National Taiwan University Hospital

Taipei, 10002, Taiwan
Northwest Cancer Specialists - Vancouver

Vancouver, Washington, 98684, United States
Research Medical Center

Kansas City, Missouri, 64132, United States
SCRI Florida Cancer Specialists South

Fort Myers, Florida, 33901, United States
SCRI Tennessee Oncology

Nashville, Tennessee, 37203, United States
Seoul National University Bundang Hospital

Gyeonggi-do, 13620, South Korea
Seoul National University Hospital

Seoul, 03080, South Korea
Severance Hospital, Yonsei University Health System

Seoul, 03722, South Korea
Taipei Medical University ?Shuang Ho Hospital

New Taipei City, 23561, Taiwan
Taipei Veterans General Hospital

Taipei, 1121, Taiwan
University of Kansas Medical Center

Westwood, Kansas, 66205, United States
Virginia Cancer Specialists, PC

Fairfax, Virginia, 22031, United States

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER